Sign in
4

Changes in Ownership

Vaxcyte, Inc. Filed Acc 0001649094-25-000045

SVP, GEN COUNSEL & CORP SEC sold 5,000 shares at an average $70.74 ($353,699)

  • SVP, GEN COUNSEL & CORP SEC acquired 5,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2025-03-05 Option exercise 10b5-1 +5,000 $21.41 $107,050 46,620 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2025-03-05 Sale 10b5-1 −2,621 $70.39 $184,487 43,999 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2025-03-05 Sale 10b5-1 −2,267 $71.07 $161,107 41,732 D
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2025-03-05 Sale 10b5-1 −112 $72.37 $8,105 41,620 D
Derivatives
Eydelman Mikhail SVP, GEN COUNSEL & CORP SEC 2025-03-05 Option exercise · Stock Option (right to buy) 10b5-1 −5,000 144,497 D
Open-market sales · 5,000 sh · avg $70.74 · $353,699
Loading xslF345X05/wk-form4_1741383777.xml…